176 related articles for article (PubMed ID: 9635147)
1. Scavestrogen sulfamates: correlation between estrone sulfatase inhibiting and antioxidant effects.
Römer W; Oettel M; Schwarz S
Can J Physiol Pharmacol; 1998 Feb; 76(2):99-109. PubMed ID: 9635147
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of estrone sulfatase by aromatase inhibitor-based estrogen 3-sulfamates.
Numazawa M; Tominaga T; Watari Y; Tada Y
Steroids; 2006 May; 71(5):371-9. PubMed ID: 16476457
[TBL] [Abstract][Full Text] [Related]
3. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
[TBL] [Abstract][Full Text] [Related]
4. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.
Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348
[TBL] [Abstract][Full Text] [Related]
5. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase parallel synthesis of 17alpha-substituted estradiol sulfamate and phenol libraries using the multidetachable sulfamate linker.
Ciobanu LC; Poirier D
J Comb Chem; 2003; 5(4):429-40. PubMed ID: 12857111
[TBL] [Abstract][Full Text] [Related]
7. Novel "scavestrogens" and their radical scavenging effects, iron-chelating, and total antioxidative activities: delta 8,9-dehydro derivatives of 17 alpha-estradiol and 17 beta-estradiol.
Römer W; Oettel M; Droescher P; Schwarz S
Steroids; 1997 Mar; 62(3):304-10. PubMed ID: 9071739
[TBL] [Abstract][Full Text] [Related]
8. Sulfamoyloxy-substituted 2-phenylindoles: antiestrogen-based inhibitors of the steroid sulfatase in human breast cancer cells.
Golob T; Liebl R; von Angerer E
Bioorg Med Chem; 2002 Dec; 10(12):3941-53. PubMed ID: 12413846
[TBL] [Abstract][Full Text] [Related]
9. Development of potent non-estrogenic estrone sulfatase inhibitors.
Li PK; Chu GH; Guo JP; Peters A; Selcer KW
Steroids; 1998; 63(7-8):425-32. PubMed ID: 9654650
[TBL] [Abstract][Full Text] [Related]
10. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
[TBL] [Abstract][Full Text] [Related]
11. Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Winiski AP; Billich A
J Med Chem; 2003 Nov; 46(23):5091-4. PubMed ID: 14584960
[TBL] [Abstract][Full Text] [Related]
12. Novel estrogens and their radical scavenging effects, iron-chelating, and total antioxidative activities: 17 alpha-substituted analogs of delta 9(11)-dehydro-17 beta-estradiol.
Römer W; Oettel M; Menzenbach B; Droescher P; Schwarz S
Steroids; 1997 Nov; 62(11):688-94. PubMed ID: 9366006
[TBL] [Abstract][Full Text] [Related]
13. Aryl sulfamates are broad spectrum inactivators of sulfatases: effects on sulfatases from various sources.
Bojarová P; Williams SJ
Bioorg Med Chem Lett; 2009 Jan; 19(2):477-80. PubMed ID: 19058962
[TBL] [Abstract][Full Text] [Related]
14. Estrogenicity, antiestrogenicity and estrone sulfatase inhibition of estrone-3-amine and estrone-3-thiol.
Selcer KW; Li PK
J Steroid Biochem Mol Biol; 1995 Mar; 52(3):281-6. PubMed ID: 7696150
[TBL] [Abstract][Full Text] [Related]
15. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
16. 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Lehr P; Billich A
J Med Chem; 2002 Sep; 45(19):4310-20. PubMed ID: 12213072
[TBL] [Abstract][Full Text] [Related]
17. Non-steroidal and steroidal sulfamates: new drugs for cancer therapy.
Purohit A; Woo LW; Barrow D; Hejaz HA; Nicholson RI; Potter BV; Reed MJ
Mol Cell Endocrinol; 2001 Jan; 171(1-2):129-35. PubMed ID: 11165021
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant properties of extracts from Alchornea laxiflora (Benth) Pax and Hoffman.
Farombi EO; Ogundipe OO; Samuel Uhunwangho E; Adeyanju MA; Olarenwaju Moody J
Phytother Res; 2003 Aug; 17(7):713-6. PubMed ID: 12916064
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
Selcer KW; Jagannathan S; Rhodes ME; Li PK
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
[TBL] [Abstract][Full Text] [Related]
20. Stilbene-based inhibitors of estrone sulfatase with a dual mode of action in human breast cancer cells.
Walter G; Liebl R; von Angerer E
Arch Pharm (Weinheim); 2004 Dec; 337(12):634-44. PubMed ID: 15597397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
